GLENMERE PHARMS
LIVE

Serial Number

99593876

Owner

Sha-Ron Pierre-Kovler

Attorney

Stefan Knirr

Filing Date

Jan 14, 2026

Add to watchlist:

No watchlists yet
View on USPTO

GLENMERE PHARMS Trademark

Serial Number: 99593876

GLENMERE PHARMS is a trademark filed by Sha-Ron Pierre-Kovler on January 14, 2026. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Sha-Ron Pierre-Kovler (5 trademarks)

299 Pine Hill Rd
Chester, NY 10918

Entity Type: 01

Trademark Details

Filing Date

January 14, 2026

Registration Date

Not Registered

Published for Opposition

June 9, 2026

Goods & Services

Educational services namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, and cancer treatment; instruction and training services, in the field of pharmaceutical product development of medicines and cancer treatments; education services relating to medicine, namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, and cancer treatment; organising and conducting seminars and conventions in the field of medicine; information, advisory and consultancy services in relation to all of the aforesaid services.

Scientific and technological services, namely, scientific research, analysis, testing in the field of medicines, healthcare, and cancer treatment, and research and design relating thereto; chemical analysis; chemical research; research and development of new products for others; research and development on the subject of pharmaceuticals; consultancy relating to pharmaceutical research and development; conducting clinical trials in the field of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; information, advisory and consultancy services in relation to all of the aforesaid services.

Medical services, veterinary services, and medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Pharmaceutical compounding services; Pharmaceutical advisory services, namely, providing pharmaceutical advice; Provision of pharmaceutical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing information in the field of medicine; horticultural services; information, advisory and consultancy services in relation to all of the aforesaid

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 9, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 9, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 3, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 14, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
May 14, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 14, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
May 14, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 14, 2026 CNEA
ASSIGNED TO EXAMINER
May 12, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 6, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 14, 2026 MAFR
NEW APPLICATION ENTERED
Jan 14, 2026 NWAP